Sort   by:  
 Page size 
UnknownA systematic study of nitrated indenoisoquinolines reveals a potent topoisomerase I inhibitor.
Not available
S-EPMC2526352 | biostudies-literature
UnknownPosition-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine.
Not available
S-EPMC27093 | biostudies-literature
UnknownBenzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages.
Not available
S-EPMC15750 | biostudies-literature
UnknownHuman mitochondrial topoisomerase I.
Not available
S-EPMC58513 | biostudies-literature
UnknownPosition-specific trapping of topoisomerase II by benzo[a]pyrene diol epoxide adducts: implications for interactions with intercalating anticancer agents.
Not available
S-EPMC218786 | biostudies-literature
UnknownSynthesis and evaluation of indenoisoquinoline topoisomerase I inhibitors substituted with nitrogen heterocycles.
Not available
S-EPMC2526314 | biostudies-literature
UnknownPlatelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic Thrombocytopenia.
Not available
S-EPMC12676393 | biostudies-literature
UnknownAnti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin.
Not available
S-EPMC8491860 | biostudies-literature
UnknownMonoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT.
Not available
S-EPMC9262283 | biostudies-literature
UnknownThe effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Not available
S-EPMC3145073 | biostudies-literature
Sort   by:  
 Page size